Skip to content
Studies out of Isreal, Italy, Spain, China, Germany and other European countries have added to the wide body of research on cannabinoids and migraine.
A recent study out of Italy suggests that genetic deficiencies may be at play in severe headaches and migraine.
The majority of studies used purified Cannabidiol – or CBD, which does not create a high for those taking it.
The study concluded that “the potential effects of cannabinoids on serotonin in the central nervous system indicate that marijuana may be a therapeutic alternative.”
“Endocannabinoids in chronic migraine. Findings suggest a system failure” was published in the medical journal Neuropsychopharmacology in 2017.
Fewer migraines in Colorado
A study out of Colorado found that 121 adult migraineurs suffered fewer migraines the use of cannabis over a 4.5-year period .
Headache frequency decreased from 10.4 to 4.6 headaches per month.
Most study participants took cannabis daily to help ward off potential migraines.
Experiences with the edible forms of cannabis were reportedly more negative, with inhaling most commonly used for acute migraines among study participants.
Just over a tenth of participants reported negative effects when taking cannabis.